Clinical Search and Evaluation Lead
UCB Pharma
Clinical Search and Evaluation Lead
UCB Pharma
Biopharmaceuticals for neurology and immunology therapies
Make your mark for patients
We are looking for a Clinical Search and Evaluation Lead Neurology to join our neurology Search and Evaluation remote team, based in either Brussels, Belgium; Monheim, Germany; or Slough, United Kingdom. Other locations may be considered case by case.
About the role
Join us in identifying and evaluating external clinical innovation in neurology. You will monitor the external neuroscience landscape to identify clinical-stage opportunities with the potential to deliver meaningful impact for patients. Combining deep knowledge of neurology, clinical development and trial design, you will interpret complex clinical data, assess development plans, and determine which external opportunities should be prioritized. You will scout the landscape, engage with specialists and innovators, and translate scientific and clinical evidence into clear, informed recommendations. Your assessments will balance scientific and clinical promise, patient need, development feasibility, risk and cost.
Who you'll work with
You will work closely with our Scientific Search & Evaluation team to ensure broad coverage of the external neuroscience innovation landscape and the identification of scientifically differentiated clinical opportunities aligned with our priorities in neurology as well as with Business Development. You will collaborate with broad range of cross-functional experts to evaluate evidence, challenge assumptions and assess the feasibility and potential value of opportunities. You will build trusted relationships with external scientists, clinicians, innovators and industry specialists, helping us stay ahead of emerging science, clinical developments and new treatment approaches in neurology.
What you'll do
Interested? For this role we're looking for the following education, experience and skills
Are you ready to ‘go beyond’ to create value and make your mark for patients? If this sounds like you, then we would love to hear from you!
About us
UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe, inspired by patients and driven by science.
Why work with us?
At UCB, we don’t just complete tasks, we create value. We aren’t afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We ‘go beyond’ to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.
At UCB, we’ve embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.
UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on [email protected]. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.
Biopharmaceuticals for neurology and immunology therapies
UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.
Explore more opportunities at UCB Pharma